A Comparison Of The Effect Of Target-Controlled Infusion Anesthesia And Inhalation Anesthesia

A Comparison Of The Effect Of Target-Controlled Infusion Anesthesia And Inhalation Anesthesia On Patient Outcomes In Pediatric Patients Undergoing Endovascular Intervention

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06265610

Enrollment

Registered

2024-02-20

Start date

2022-03-01

Completion date

2023-10-01

Last updated

2024-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiology, Pediatric Patients

Keywords

Sevoflurane,, Propofol, Target Controlled Infusion,

Brief summary

A total of 70 patients who underwent angiographic examination, ASD closure, VSD closure, PDA closure and aortic balloon dilatation were included in this study.

Detailed description

A total of 70 patients who underwent angiographic examination, ASD closure, VSD closure, PDA closure and aortic balloon dilatation were included in this study. Patients underwent standard electrocardiography (ECG) monitoring with heart rate (HR), noninvasive blood pressure (NIKB), peripheral oxygen saturation (SpO2) and Bispectral index (BIS). Baseline NIKB, SpO2 and HR were recorded before the procedure, intraoperatively and in the postoperative recovery unit. In the postoperative recovery unit, the patient's recovery time was also evaluated and recorded with the Modified Aldrete Recovery Score.

Interventions

PROCEDURETIVA/TCI

: The aim of this study was to evaluate the effects of total intravenous anesthesia with target-controlled infusion (TCI/TIVA) on intraoperative hemodynamic parameters and postoperative awakening criteria in pediatric endovascular intervention patients

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

3 Years to 18 Years

Healthy volunteers

Yes

Inclusion criteria

1. Children weighing over 10 kg and between the ages of 3-18 who will undergo angiography 2. Patients who are not allergic to the drugs used

Exclusion criteria

1. ASA Ⅳ patients 2. Patients with Diabetes Mellitus 3. Patients with severe lung disease 4. Patients with psychiatric disorders 5. Patients with opioid addiction -

Design outcomes

Primary

Measure	Time frame	Description
intraoperative period	an average of 2 hours	During cardiology angiography procedures, patients' heart rate,measurements will be evaluated.
postoperative period	an average of 2 hours	During cardiology angiography procedures, patients' eye opening time will be evaluated.
hemodynamic parameters	an average of 2 hours	During cardiology angiography procedures, patienheart ts' mean arterial pressure (MAP),measurements will be evaluated.

Secondary

Measure	Time frame	Description
Modified Aldrete Recovery Score	during the processing period	Modified Aldrete Recovery Score will be evaluated in the postoperative period

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026